Free Trial

3,854 Shares in CVS Health Corporation (NYSE:CVS) Bought by First Interstate Bank

CVS Health logo with Medical background

First Interstate Bank bought a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,854 shares of the pharmacy operator's stock, valued at approximately $261,000.

Several other institutional investors have also recently made changes to their positions in CVS. Proficio Capital Partners LLC bought a new stake in CVS Health in the fourth quarter worth $5,544,000. OFI Invest Asset Management bought a new position in shares of CVS Health in the 4th quarter worth approximately $65,000. Sowell Financial Services LLC boosted its holdings in CVS Health by 17.4% in the fourth quarter. Sowell Financial Services LLC now owns 38,370 shares of the pharmacy operator's stock worth $1,722,000 after acquiring an additional 5,689 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in CVS Health by 21.8% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 318,089 shares of the pharmacy operator's stock worth $14,279,000 after acquiring an additional 56,895 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its holdings in shares of CVS Health by 7.8% during the fourth quarter. Daiwa Securities Group Inc. now owns 165,314 shares of the pharmacy operator's stock valued at $7,421,000 after buying an additional 11,955 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research reports. Mizuho boosted their target price on shares of CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Robert W. Baird lifted their price objective on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Cowen reaffirmed a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Royal Bank Of Canada lifted their target price on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Finally, Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, CVS Health presently has an average rating of "Moderate Buy" and an average target price of $75.06.

Get Our Latest Analysis on CVS Health

Insiders Place Their Bets

In related news, Director Guy P. Sansone purchased 1,570 shares of the business's stock in a transaction on Thursday, June 5th. The shares were bought at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Price Performance

NYSE:CVS traded down $0.96 during trading hours on Thursday, hitting $65.70. The company's stock had a trading volume of 2,842,613 shares, compared to its average volume of 10,785,662. The business's 50-day moving average is $65.18 and its two-hundred day moving average is $61.93. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $72.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The company has a market capitalization of $83.11 billion, a PE ratio of 15.67, a PEG ratio of 0.96 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping the consensus estimate of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 EPS. As a group, research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 4.05%. CVS Health's payout ratio is currently 63.48%.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Should You Invest $1,000 in CVS Health Right Now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines